Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-26 Sale |
2024-03-27 4:30 pm |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
190,476 | $21.5 | $4,095,234 | 970,229 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-26 Option Award |
2025-03-28 5:20 pm |
N/A N/A |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
64,783 | $0 | 294,264 (Direct) |
View |
| 2025-03-26 Exercise |
2025-03-28 5:20 pm |
N/A N/A |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
45,481 | $0 | 294,264 (Direct) |
View |
| 2025-03-24 Exercise |
2025-03-26 4:27 pm |
N/A 2031-07-06 |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
150,000 | $0 | 970,229 (Indirect) |
View |
| 2025-01-07 Option Award |
2025-01-07 5:21 pm |
N/A N/A |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
34,000 | $0 | 34,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:48 pm |
N/A 2035-01-02 |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-03-26 Tax Withholding |
2024-03-27 4:30 pm |
N/A N/A |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
11,197 | $22.72 | 970,229 (Indirect) |
View |
| 2024-03-26 Exercise |
2024-03-27 4:30 pm |
N/A 2031-07-06 |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
201,673 | $0 | 970,229 (Indirect) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:17 pm |
N/A 2034-01-01 |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
500,000 | $0 | 500,000 (Direct) |
View |
Ownership |
2023-12-29 4:30 pm |
N/A 2033-01-01 |
NewAmsterdam Pharma Co N.V. | NAMS | Kastelein Johannes Jacob Pieter Chief Scientific Officer |
0 | $0 | 2,620,975 (Direct) |
View |